Waters Stock Price, News & Analysis

Waters Corporation (NYSE:WAT) has launched advanced powder rheology capabilities for its HR Rheometer, enhancing its versatility in characterizing liquids, solids, and powders. The new SmartSwap™ tooling allows quick transitions between liquid and powder measurements in just 10 seconds, improving sample preparation speed by three times compared to competitors. This innovative technology supports industries like lithium-ion batteries and pharmaceuticals, ensuring accurate data for optimizing materials and processing. The powder rheology accessory is available for existing or new HR Rheometers.

Waters Corporation announced the opening of a new $215M Precision Chemical Manufacturing Facility in Taunton, Massachusetts, achieving LEED certification from the U.S. Green Building Council. This facility will enhance production for essential products in the development and testing of vaccines and medicines, creating 25 new jobs and significantly increasing operational efficiency. Waters' facility is the first LEED-certified chemical manufacturing plant in Massachusetts, promoting environmental sustainability in its operations.

Waters Corporation (NYSE:WAT), under CEO Udit Batra, will join the Bank of America 2022 Global Healthcare Conference in London on September 14, 2022, at 9:05 AM BST. Investors can tune into the event via a live webcast on the company’s investor relations website. A recorded replay will be accessible for 30 days post-event. With over 60 years of experience, Waters is a leader in analytical instruments and software, employing 7,800 staff across 35 countries and operating 14 manufacturing facilities.

Waters Corporation (NYSE: WAT) reported second-quarter 2022 sales of $714 million, a 5% increase from the previous year and 10% in constant currency. Instrument sales rose 12% in constant currency, driven by robust performance across product lines. Recurring revenues grew by 8% in constant currency. GAAP EPS was $2.72 and non-GAAP EPS increased 6% to $2.75. For the first half of 2022, sales were $1,405 million, up 9% as reported, with full-year 2022 guidance raised, anticipating 9.5% to 10.5% constant currency sales growth.

Waters Corporation (NYSE:WAT) announced its collaboration with the Plant Protein Innovation Center at the University of Minnesota to advance plant-based protein science. The partnership will leverage Waters’ ACQUITY Premier UPLC System to establish a standard workflow for amino acid analysis, vital for evaluating alternative proteins. With projections showing that plant proteins could secure an 11% market share by 2035, Waters aims to support the transition to healthier and sustainable dietary options while addressing climate change and food security challenges.

Waters Corporation (NYSE:WAT) will host its Q2 2022 financial results conference call on August 2, 2022, at 8:00 a.m. ET. The event will be accessible via a live webcast on Waters' investor relations site, with a replay available until August 16, 2022. Waters, a leader in analytical instruments and software, has been innovating in chromatography and mass spectrometry for over 60 years, employing more than 7,800 people and operating in over 35 countries.

Waters Corporation (NYSE:WAT) has partnered with BioInfra to launch the ASEAN Academy for Bioanalysis in South Korea. This training facility aims to equip scientists with essential bioanalytical skills required for drug discovery and development, addressing the increasing demand for low-cost generic drugs in Southeast Asia. The academy will focus on bioequivalence trials, enhancing the region's scientific competitiveness and pharmaceutical research quality, ultimately benefiting the growing elderly population facing health challenges.

Waters Corporation (NYSE:WAT) introduced the Xevo G3 quadrupole time-of-flight mass spectrometer, boasting up to 10X more sensitivity than its predecessor. The launch, announced at the ASMS 2022 Annual Conference, aims to enhance drug discovery and development. Additionally, the new CONFIRM Sequence app streamlines nucleic acid sequencing confirmation, cutting data review time by 50%. Finally, the integration of a new electrospray ionization source with the SELECT SERIES MRT system enables rapid molecular characterization.

Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., President and CEO, will engage in a fireside chat at the Jefferies 2022 Global Healthcare Conference in New York City on June 8th, 2022, at 4:30 PM EST. Interested investors can access the live webcast via Waters' investor relations website, which will be available for replay for 30 days. Waters has been a leader in analytical instruments for over 60 years, operating in 35 countries with a workforce exceeding 7,800 employees.